ArticleHuman vaccines & immunotherapeutics2018

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age.

E D Moreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.